| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.43 | 0.008 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |